Skip directly to page options Skip directly to A-Z link
Volume 31, Number 5—May 2025
Research

Exponential Clonal Expansion of 5-Fluorocytosine–Resistant Candida tropicalis and New Insights into Underlying Molecular Mechanisms

Nissrine Abou-Chakra, Karen Marie Thyssen Astvad, Jan Martinussen, Amalie Sofie Eilsø Munksgaard, and Maiken Cavling ArendrupComments to Author 
Author affiliation: Author affiliations: Statens Serum Institut, Copenhagen, Denmark (N. Abou-Chakra, K.M.T. Astvad, A.S.E. Munksgaard, M.C. Arendrup); Technical University of Denmark, Kgs Lyngby, Denmark (J. Martinussen); University of Copenhagen, Copenhagen (A.S.E. Munksgaard, M.C. Arendrup); Rigshospitalet, Copenhagen (M.C. Arendrup)

Main Article

Table 2

5-fluorocytosine susceptibility of Candida spp. in study of clonal expansion of 5-fluorocytosine–resistant Candida tropicalis, Denmark*

Year sampled MIC, mg/L
Total Wild-type UL, mg/L Non–wild-type rate, %
<0.016 0.03 0.06 0.125 0.25 0.5 1 2 4 8 16 >16
C. tropicalis
1998–2004 0 1 2 17 4 0 0 0 0 0 0 1 25 0.5 4.0
2011–12 0 0 12 7 0 0 0 0 0 0 0 4 23 0.5 17.4
2022
1
1
9
18
2
1
0
0
0
0
3
29
64
0.5
50.0
C. albicans
2022
0
2
8
144
154
28
14
2
0
0
0
1
353
1
0.8
C. glabrata
2022 1 8 86 122 5 0 1 1 3 0 0 0 227 0.25 2.2

*The reference strain, Candida tropicalis ATCC 750, had a MIC of 0.06 mg/L. Bold text indicates non–wild-type isolates. UL, upper limit.

Main Article

Page created: April 14, 2025
Page updated: April 25, 2025
Page reviewed: April 25, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external